©2022 Stanford Medicine
Early Screening and Treatment of Women With Prediabetes in Pregnancy
Not Recruiting
Trial ID: NCT01552213,25512
Purpose
The investigators hope to learn whether treatment with medical nutrition therapy (MNT) for
pregnant women with prediabetes decreases the rate and severity of impaired glucose tolerance
later in pregnancy and improves perinatal outcomes. Given the rising rates of obesity and
diabetes in this country even among young women and the adverse affects of diabetes of
pregnant women and their infants, the investigators feel that it is important to not only
identify women at high risk for diabetes early in pregnancy but determine the appropriate
management strategy
Official Title
A Randomized Controlled Trial of Early Screening and Treatment of Women With Prediabetes in Pregnancy
Stanford Investigator(s)
Yasser El-Sayed, Professor
Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery
Eligibility
Inclusion Criteria:
- Age 18 or older
- Singleton pregnancy
- Prenatal care established at less than 14 weeks
- A1C 5.7-6.4%
- Delivery planned at Lucille Packard Children's Hospital at Stanford University (LPCH)
or Santa Clara Valley Medical Center (SVMC)
Exclusion Criteria:
- preexisting diabetes or chronic steroid use
- known major fetal anomalies
Intervention(s):
other: Minimum intervention control group
other: Treatment for glucose intolerance
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Sarah S Osmundson, MD
312-479-3130